Table 5. Distribution (percentage of isolates) of minimum inhibitory concentration (MIC) and prevalence of non-WT or resistance (R, shown as percentage) for group B Streptococcus (n = 58) isolated from lactating camels and their calves in Laikipia County, Kenya, 20191.
Distribution (%) of MICs (μg/mL) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Test agent | % R | ≤0.03 | 0.06 | 0.125 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 |
Cephalotin | 0 | 100 | |||||||||||
Clindamycin | 0 | 100 | |||||||||||
Enrofloxacin | NA | 70.7 | 29.3 | ||||||||||
Erytromycin | 0 | 100 | |||||||||||
Gentamicin | 0 | 5.2 | 65.5 | 29.3 | |||||||||
Nitrofurantoin | 0 | 100 | |||||||||||
Penicillin | 0 | 27.6 | 72.4 | ||||||||||
Tetracycline | 57 | 39.7 | 3.4 | 1.7 | 55.2 | ||||||||
Trimethoprim-Sulfametoxazol | 0 | 100 |
1Unshaded cells indicate the range of concentrations tested for each antimicrobial agent. Shaded cells indicate concentrations outside the range tested for each substance. MIC equal to or lower than the lowest concentration tested for an antibiotic substance (≤Y μg/mL), is given as a percentage at the lowest tested concentration. Blank unshaded cells indicate lack of isolates with that MIC. Bold vertical lines indicate epidemiological cut-off values retrieved from the European Committee on Antimicrobial Susceptibility Testing or, for cephalotin and trimethropim-sulfametoxazole, clinical breakpoints from SVA.